Hepatitis delta virus: Making the point from virus isolation up to 2014

World Journal of Hepatology

Volumn 7, Issue 22, 2015, Pages 2389-2395

  Romeo, Raffaella ^a   Perbellini, Riccardo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Epidemiology; Hepatitis delta virus; Natural history; Treatment

Indexed keywords

EID: 84943427382     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i22.2389     Document Type: Short Survey

References (49)

1. Rizzetto M, Canese MG, Aricò S, Crivelli O, Trepo C, Bonino F, Verme G. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977;18:997-1003 [PMID:75123 DOI:10.1136/gut.18.12.997]
2. Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL, Purcell RH. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis 1980;141:590-602 [PMID:6989929 DOI:10.1093/infdis/141.5.590]
3. Rizzetto M, Ponzetto A, Forzani I. Epidemiology of hepatitis delta virus:overview. Prog Clin Biol Res 1991;364:1-20 [PMID:2020686]
4. Romeo R, Del Ninno E, Rumi M, Russo A, Sangiovanni A, de Franchis R, Ronchi G, Colombo M. A 28-year study of the course of hepatitis Delta infection:a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology 2009;136:1629-1638 [PMID:19208358 DOI:10.1053/j.gastro.2009.01.052]
5. Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, Schalm SW. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut 2000;46:420-426 [PMID:10673308 DOI:10.1136/gut.46.3.420]
6. Rizzetto M, Hoyer B, Canese MG, Shih JW, Purcell RH, Gerin JL. delta Agent:association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci USA 1980;77:6124-6128 [PMID:6934539 DOI:10.1073/pnas.77.10.6124]
7. Wang KS, Choo QL, Weiner AJ, Ou JH, Najarian RC, Thayer RM, Mullenbach GT, Denniston KJ, Gerin JL, Houghton M. Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature 1986;323:508-514 [PMID:3762705 DOI:10.1038/323508a0]
8. Tsatsralt-Od B, Takahashi M, Nishizawa T, Endo K, Inoue J, Okamoto H. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. J Med Virol 2005;77:491-499 [PMID:16254981 DOI:10.1002/jmv.20482]
9. Sagnelli E, Stroffolini T, Ascione A, Chiaramonte M, Craxì A, Giusti G, Piccinino F. Decrease in HDV endemicity in Italy. J Hepatol 1997;26:20-24 [PMID:9148012 DOI:10.1016/S0168-8278(97)80004-9]
10. Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, Lobello S, Sagnelli E, Brunetto MR, Rizzetto M. Chronic hepatitis D:a vanishing Disease? An Italian multicenter study. Hepatology 2000;32:824-827 [PMID:11003629 DOI:10.1053/jhep.2000.17711]
11. Navascués CA, Rodríguez M, Sotorrío NG, Sala P, Linares A, Suárez A, Rodrigo L. Epidemiology of hepatitis D virus infection: changes in the last 14 years. Am J Gastroenterol 1995;90: 1981-1984 [PMID:7485005]
12. Huo TI, Wu JC, Lin RY, Sheng WY, Chang FY, Lee SD. Decreasing hepatitis D virus infection in Taiwan:an analysis of contributory factors. J Gastroenterol Hepatol 1997;12:747-751 [PMID:9430041 DOI:10.1111/j.1440-1746.1997.tb00364.x]
13. Degertekin H, Yalçin K, Yakut M. The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: an analysis of clinical studies. Turk J Gastroenterol 2006;17: 25-34 [PMID:16830274]
14. Degertekin H, Yalçin K, Yakut M, Yurdaydin C. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey:a meta-analysis. Liver Int 2008;28:494-498 [PMID:18339076 DOI:10.1111/j.1478-3231.2008.01673.x]
15. Abbas Z, Jafri W, Raza S. Hepatitis D:Scenario in the AsiaPacific region. World J Gastroenterol 2010;16:554-562 [PMID:20128022 DOI:10.3748/wjg.v16.i5.554]
16. Cross TJ, Rizzi P, Horner M, Jolly A, Hussain MJ, Smith HM, Vergani D, Harrison PM. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol 2008; 80:277-282 [PMID:18098143 DOI:10.1002/jmv.21078]
17. Wedemeyer H, Heidrich B, Manns MP. Hepatitis D virus infection- not a vanishing disease in Europe! Hepatology 2007;45:1331-1332; author reply 1332-1333 [PMID:17464980 DOI:10.1002/hep.21590]
18. Erhardt A, Knuth R, Sagir A, Kirschberg O, Heintges T, Häussinger D. Socioepidemiological data on hepatitis delta in a German university clinic-increase in patients from Eastern Europe and the former Soviet Union. Z Gastroenterol 2003;41:523-526 [PMID:12806537 DOI:10.1055/s-2003-39648]
19. Le Gal F, Castelneau C, Gault E, al Hawajri N, Gordien E, Marcellin P, Dény P. Reply. Hepatology 2007;45:1332-1333 [DOI:10.1002/hep.21652]
20. Nath N, Mushahwar IK, Fang CT, Berberian H, Dodd RY. Antibodies to delta antigen in asymptomatic hepatitis B surface antigen-reactive blood donors in the United States and their association with other markers of hepatitis B virus. Am J Epidemiol 1985;122:218-225 [PMID:4014206]
21. De Cock KM, Niland JC, Lu HP, Rahimian A, Edwards V, Shriver K, Govindarajan S, Redeker AG. Experience with human immunodeficiency virus infection in patients with hepatitis B virus and hepatitis delta virus infections in Los Angeles, 1977-1985. Am J Epidemiol 1988;127:1250-1260 [PMID:3369423]
22. Hershow RC, Chomel BB, Graham DR, Schyve PM, Mandel EJ, Kane MA, Fields HA, Hadler SC. Hepatitis D virus infection in Illinois state facilities for the developmentally disabled. Epidemiology and clinical manifestations. Ann Intern Med 1989;110: 779-785 [PMID:2712461 DOI:10.7326/0003-4819-110-10-779]
23. Novick DM, Farci P, Croxson TS, Taylor MB, Schneebaum CW, Lai ME, Bach N, Senie RT, Gelb AM, Kreek MJ. Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. J Infect Dis 1988;158:795-803 [PMID:3171227 DOI:10.1093/infdis/158.4.795]
24. Kucirka LM, Farzadegan H, Feld JJ, Mehta SH, Winters M, Glenn JS, Kirk GD, Segev DL, Nelson KE, Marks M, Heller T, Golub ET. Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users. J Infect Dis 2010;202:845-852 [PMID:20701536 DOI:10.1086/655808]
25. Gish RG, Yi DH, Kane S, Clark M, Mangahas M, Baqai S, Winters MA, Proudfoot J, Glenn JS. Coinfection with hepatitis B and D:epidemiology, prevalence and disease in patients in Northern California. J Gastroenterol Hepatol 2013;28:1521-1525 [PMID:23574043 DOI:10.1111/jgh.12217]
26. Dimitrakakis M, Gust I. HDV infection in the Western Pacific region. Prog Clin Biol Res 1991;364:89-96 [PMID:2020726]
27. Viana S, Paraná R, Moreira RC, Compri AP, Macedo V. High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon. Am J Trop Med Hyg 2005;73:808-814 [PMID:16222030]
28. Ponzetto A, Hoyer BH, Popper H, Engle R, Purcell RH, Gerin JL. Titration of the infectivity of hepatitis D virus in chimpanzees. J Infect Dis 1987;155:72-78 [PMID:3794405 DOI:10.1093/infdis/155.1.72]
29. Wu JC, Chen CM, Sheen IJ, Lee SD, Tzeng HM, Choo KB. Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome. Hepatology 1995;22:1656-1660 [PMID:7489970 DOI:10.1002/hep.1840220607]
30. Rosenblum L, Darrow W, Witte J, Cohen J, French J, Gill PS, Potterat J, Sikes K, Reich R, Hadler S. Sexual practices in the transmission of hepatitis B virus and prevalence of hepatitis delta virus infection in female prostitutes in the United States. JAMA 1992;267:2477-2481 [PMID:1573724 DOI:10.1001/jama.1992.03480180063030]
31. Smedile A, Farci P, Verme G, Caredda F, Cargnel A, Caporaso N, Dentico P, Trepo C, Opolon P, Gimson A, Vergani D, Williams R, Rizzetto M. Influence of delta infection on severity of hepatitis B. Lancet 1982;2:945-947 [PMID:6127458 DOI:10.1016/S0140-6736(82)90156-8]
32. Smedile A, Dentico P, Zanetti A, Sagnelli E, Nordenfelt E, Actis GC, Rizzetto M. Infection with the delta agent in chronic HBsAg carriers. Gastroenterology 1981;81:992-997 [PMID:7286594 DOI:10.1016/S0016-5085(81)80003-0]
33. Radjef N, Gordien E, Ivaniushina V, Gault E, Anaïs P, Drugan T, Trinchet JC, Roulot D, Tamby M, Milinkovitch MC, Dény P. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol 2004;78:2537-2544 [PMID:14963156 DOI:10.1128/JVI.78.5.2537-2544.2004]
34. Hsu SC, Syu WJ, Sheen IJ, Liu HT, Jeng KS, Wu JC. Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implications. Hepatology 2002;35: 665-672 [PMID:11870382 DOI:10.1053/jhep.2002.31777]
35. Lin FM, Lee CM, Wang TC, Chao M. Initiation of RNA replication of cloned Taiwan-3 isolate of hepatitis delta virus genotype II in cultured cells. Biochem Biophys Res Commun 2003;306:966-972 [PMID:12821137 DOI:10.1016/S0006-291X(03)01076-3]
36. Su CW, Huang YH, Huo TI, Shih HH, Sheen IJ, Chen SW, Lee PC, Lee SD, Wu JC. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Gastroenterology 2006;130:1625-1635 [PMID:16697726 DOI:10.1053/j.gastro.2006.01.035]
37. Romeo R, Foglieni B, Casazza G, Spreafico M, Colombo M, Prati D. High serum levels of HDV RNA are predictors of cirrhosis and liver cancer in patients with chronic hepatitis delta. PLoS One 2014;9:e92062 [PMID:24658127 DOI:10.1371/journal.pone.0092062]
38. Nakano T, Shapiro CN, Hadler SC, Casey JL, Mizokami M, Orito E, Robertson BH. Characterization of hepatitis D virus genotype III among Yucpa Indians in Venezuela. J Gen Virol 2001;82: 2183-2189 [PMID:11514728 DOI:10.1099/0022-1317-82-9-2183]
39. Hadziyannis SJ. Use of alpha-interferon in the treatment of chronic delta hepatitis. J Hepatol 1991;13 Suppl 1:S21-S26 [PMID:1835731 DOI:10.1016/0168-8278(91)91716-T]
40. Farci P, Mandas A, Coiana A, Lai ME, Desmet V, Van Eyken P, Gibo Y, Caruso L, Scaccabarozzi S, Criscuolo D. Treatment of chronic hepatitis D with interferon alfa-2a. N Engl J Med 1994;330: 88-94 [PMID:8259188 DOI:10.1056/NEJM199401133300202]
41. Niro GA, Ciancio A, Tillman HL, Lagget M, Olivero A, Perri F, Fontana R, Little N, Campbell F, Smedile A, Manns MP, Andriulli A, Rizzetto M. Lamivudine therapy in chronic delta hepatitis:a multicentre randomized-controlled pilot study. Aliment Pharmacol Ther 2005;22:227-232 [PMID:16091060 DOI:10.1111/j.1365-2036.2005.02542.x]
42. Yurdaydin C, Bozkaya H, Gürel S, Tillmann HL, Aslan N, OkçuHeper A, Erden E, Yalçin K, Iliman N, Uzunalimoglu O, Manns MP, Bozdayi AM. Famciclovir treatment of chronic delta hepatitis. J Hepatol 2002;37:266-271 [PMID:12127433 DOI:10.1016/S0168-8278(02)00162-9]
43. Garripoli A, Di Marco V, Cozzolongo R, Costa C, Smedile A, Fabiano A, Bonino F, Rizzetto M, Verme G, Craxi A. Ribavirin treatment for chronic hepatitis D:a pilot study. Liver 1994;14: 154-157 [PMID:8078394 DOI:10.1111/j.1600-0676.1994.tb00065.x]
44. Onder FO, Yakut M, Idilman R, Seven G, Kabacam G, Karatayli E, Celik Y, Bozkaya H, Bozdayi A, Yurdaydin C. Entecavir may be beneficial in a subset of patients with chronic delta hepatitis (abstract). Hepatology 2009;50:735A [DOI:10.1002/hep.23304]
45. Niro GA, Ciancio A, Gaeta GB, Smedile A, Marrone A, Olivero A, Stanzione M, David E, Brancaccio G, Fontana R, Perri F, Andriulli A, Rizzetto M. Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. Hepatology 2006;44:713-720 [PMID:16941685 DOI:10.1002/hep.21296]
46. Erhardt A, Gerlich W, Starke C, Wend U, Donner A, Sagir A, Heintges T, Häussinger D. Treatment of chronic hepatitis delta with pegylated interferon-alpha2b. Liver Int 2006;26:805-810 [PMID:16911462 DOI:10.1111/j.1478-3231.2006.01279.x]
47. Castelnau C, Le Gal F, Ripault MP, Gordien E, Martinot-Peignoux M, Boyer N, Pham BN, Maylin S, Bedossa P, Dény P, Marcellin P, Gault E. Efficacy of peginterferon alpha-2b in chronic hepatitis delta:relevance of quantitative RT-PCR for follow-up. Hepatology 2006;44:728-735 [PMID:16941695 DOI:10.1002/hep.21325]
48. Wedemeyer H, Yurdaydìn C, Dalekos GN, Erhardt A, Çakaloglu Y, Degertekin H, Gürel S, Zeuzem S, Zachou K, Bozkaya H, Koch A, Bock T, Dienes HP, Manns MP. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med 2011;364:322-331 [PMID:21268724 DOI:10.1056/NEJMoa0912696]
49. Bordier BB, Ohkanda J, Liu P, Lee SY, Salazar FH, Marion PL, Ohashi K, Meuse L, Kay MA, Casey JL, Sebti SM, Hamilton AD, Glenn JS. In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus. J Clin Invest 2003;112:407-414 [PMID:12897208 DOI:10.1172/JCI200317704]